Revvity | PKI - Selling And Administration Expenses



Revvity reported $248.53M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Adcock Ingram Holdings ZAR 1.05B 50.17M Dec/2024
Agilent USD 417M 37M Jul/2025
Align Technology USD 448.69M 1.06M Jun/2025
Bio Techne USD 196.64M 45.37M Jun/2025
Bio-Rad Laboratories USD 207.7M 14.2M Jun/2025
Bruker USD 231.4M 6M Jun/2025
Celltrion KRW 276.8B 58.09B Mar/2025
Charles River Laboratories USD 185.82M 8.02M Jun/2025
Cspc Pharmaceutical CNY 1.89B 347.81M Mar/2025
Danaher USD 2.36B 502M Jun/2025
Dentsply International USD 334M 23M Jun/2025
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Divis Laboratories Ltd 3.4B 10M Jun/2025
Edwards Lifesciences USD 502M 36.3M Jun/2025
Exact Sciences USD 455.7M 29.3M Jun/2025
Hologic USD 251.3M 15.1M Jun/2025
Illumina USD 234M 13M Jun/2025
Intuitive Surgical USD 561.2M 2.2M Jun/2025
IQVIA Holdings USD 509M 1000K Jun/2025
Kangmei Pharma CNY 259.36M 49.8M Jun/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 579.3M 33.3M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 12.94M 5.87M Dec/2024
Mettler Toledo International USD 247.3M 4.5M Jun/2025
Myriad Genetics USD 135.7M 300K Mar/2025
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Organigram Holdings CAD 25.49M 8.3M Jun/2025
Pharma Mar EUR 14.68M 1M Jun/2025
Qiagen NV USD 148.74M 10.8M Jun/2025
Quest Diagnostics USD 486M 10M Jun/2025
Quidel USD 170.1M 203.9M Jun/2025
Repligen USD 71.23M 28K Jun/2025
Revvity USD 248.53M 1.19M Jun/2025
Sartorius EUR 225.2M 6.7M Jun/2025
Sino Biopharmaceutical CNY 5.31B 1.54B Dec/2024
Thermo Fisher Scientific USD 1.78B 58M Jun/2025
Tilray USD 72.38M 4.99M Nov/2024
Waters USD 201.26M 26.38M Jun/2025
Zz Pientze Pharmaceu -171290000 342.58M Jun/2025